| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |